Macrocephatriolides A and B: Two Guaianolide Trimers from Ainsliaea macrocephala as PTP1B Inhibitors and Insulin Sensitizers.
Yong-Mei RenRui ZhangZheling FengChang-Qiang KeSheng YaoChunping TangLigen LinYang YePublished in: The Journal of organic chemistry (2021)
Macrocephatriolides A and B (1 and 2), two novel guaiane-type sesquiterpene lactone trimers possessing unique linkage patterns, were identified from the whole plant of Ainsliaea macrocephala. The trimeric architecture of 1 features a cyclohexene linkage and a methylene bridge, which were presumably constructed from three constitutive monomers via a Diels-Alder cycloaddition and a Michael addition, respectively. The three monomers of 2 were tethered by a 1,2-ethanediyl and a methylene linkage at the same time. Their complex structures were established by extensive analysis of spectroscopic data inclusive of band-selective CT-HSQC and CT-HMBC and time-dependent density functional theory (TDDFT) ECD calculations. Compound 2 showed potent inhibition against protein tyrosine phosphatase 1B (PTP1B) with an IC50 value of 26.26 ± 0.88 μM but not compound 1. In the kinetic study, compound 2 was disclosed as a competitive inhibitor of PTP1B with a Ki value of 16.34 ± 4.72 μM. In insulin-stimulated C2C12 myotubes, compound 2 dose-dependently enhanced glucose uptake by activating the insulin signaling pathway. Compound 2 might represent a new scaffold of insulin sensitizers.
Keyphrases
- density functional theory
- type diabetes
- signaling pathway
- glycemic control
- molecular dynamics
- genome wide
- computed tomography
- image quality
- contrast enhanced
- blood pressure
- magnetic resonance imaging
- high resolution
- big data
- adipose tissue
- small molecule
- radiation therapy
- electronic health record
- insulin resistance
- skeletal muscle
- hiv infected
- mass spectrometry
- tissue engineering
- human immunodeficiency virus
- dna methylation
- deep learning
- protein protein
- rectal cancer
- protein kinase